Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections

Our objective was to describe the prescribing practices, clinical characteristics, and outcomes of patients treated with ceftolozane-tazobactam (C/T) for multidrug-resistant (MDR) Gram-negative infections. This was a multicenter, retrospective, cohort study at eight U.S. medical centers (2015 to 201...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Jorgensen, Sarah C. J., Trinh, Trang D., Zasowski, Evan J., Lagnf, Abdalhamid M., Simon, Samuel P., Bhatia, Sahil, Melvin, Sarah M., Steed, Molly E., Finch, Natalie A., Morrisette, Taylor, Estrada, Sandy J., Rosenberg, Joshua R., Davis, Susan L., Rybak, Michael J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2020
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7179316/
https://ncbi.nlm.nih.gov/pubmed/31932379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02291-19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires